PD-Rx Pharmaceuticals, Inc. (PDRX)
OTCMKTS · Delayed Price · Currency is USD
3.330
+0.430 (14.83%)
At close: Jan 12, 2026
PD-Rx Pharmaceuticals Revenue
In the fiscal year ending June 30, 2025, PD-Rx Pharmaceuticals had annual revenue of $18.35M, down -3.15%. PD-Rx Pharmaceuticals had revenue of $1.60M in the quarter ending December 31, 1999, a decrease of -2.49%.
Revenue
18.35M
Revenue Growth
-15.06%
P/S Ratio
0.30
Revenue / Employee
655.31K
Employees
28
Market Cap
5.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 18.35M | -597.71K | -3.15% |
| Jun 30, 2024 | 18.95M | -2.33M | -10.93% |
| Jun 30, 2023 | 21.27M | -7.44M | -25.92% |
| Jun 30, 2022 | 28.72M | 7.11M | 32.93% |
| Jun 30, 2021 | 21.60M | 576.65K | 2.74% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zynex | 108.20M |
| China Medicine | 65.76M |
| Exlites Holdings International | 9.42M |
| Pharmagen | 4.41M |
| Yijia Group | 2.79M |
| Gold Enterprise Group | 559.55K |
| Global Medical Products Holdings | 45.96K |
| DH Enchantment | -42.87K |